Abstract
Background: Atherosclerosis is a complex histopathologic process that is analogous to chronic inflammatory conditions. Several factors have been shown to correlate with the extent of atherosclerosis. Whereas hypertension, obesity, hyperlipidemia, diabetes, smoking, and family history are all well documented, recent literature points to additional associated factors. Thus, antibodies to oxidized low‐density lipoprotein (oxLDL), cytomegalovirus (CMV), Chlamydia pneumonia, Helicobacter pylori, as well as homocysteine and C‐reactive protein (CRP) levels have all been implicated as independent markers of accelerated atherosclerosis.
Hypothesis: In the current study we attempted to formulate a system by which to predict the extent of coronary atherosclerosis as assessed by angiographic vessel occlusion.
Methods: The 81 patients were categorized as having single‐, double‐, triple‐, or no vessel involvement. The clinical data concerning the “classic” risk factors were obtained from clinical records, and sera were drawn from the patients for determination of the various parameters that are thought to be associated with atherosclerosis.
Results: Using four artificial neural networks, we have found the most effective parameters predictive of coronary vessel involvement were (in decreasing order of importance) antibodies to oxLDL, to cardiolipin, to CMV, to Chlamydia pneumonia, and to β2‐glycoprotein I (β2GPI). Although important in the prediction of vessel occlusion, hyperlipidemia, hypertension, CRP levels, and diabetes were less accurate.
Conclusion: The results of the current study, if reproduced in a larger population, may establish an integrated system based on the creation of artificial neural networks by which to predict the extent of atherosclerosis in a given subject fairly and noninvasively.
Keywords: atherosclerosis, autoimmunity, infectious agents, oxidized low‐density lipoprotein, anticardiolipin
Full Text
The Full Text of this article is available as a PDF (433.4 KB).
Reference
- 1. Ross R: The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 1993; 362: 801–809 [DOI] [PubMed] [Google Scholar]
- 2. Wick G, Schett G, Amberger A, Kleindienst R, Xu Q: Is atherosclerosis an immunologically mediated disease? Immunol Today 1995; 16: 27–33 [DOI] [PubMed] [Google Scholar]
- 3. Libby P, Hansson GK: Involvement of the immune system in human atherogenesis: Current knowledge and unanswered questions. Lab Invest 1991; 64: 5–15 [PubMed] [Google Scholar]
- 4. Witztum JL: The oxidation hypothesis of atherosclerosis. Lancet 1994; 344: 793–795 [DOI] [PubMed] [Google Scholar]
- 5. Salonen JT, Yia‐Herttuala S, Yamamoto R, Butler S, Korpela H, Salonen R, Nyyssonen K, Palinski W, Witztum J: Antibodies against oxidized LDL and the progression of carotid atherosclerosis. Lancet 1992; 339: 883–887 [DOI] [PubMed] [Google Scholar]
- 6. Mendall MA, Patel P, Bellam L, Strachan D, Northfield TC: C‐reactive protein and its relation to cardiovascular risk factors: A population based cross sectional study. Br Med J 1996; 312: 1061–1065 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Ridker P, Cushman M, Stampfer M, Tracy R, Hennekens C: Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997; 336: 973–979 [DOI] [PubMed] [Google Scholar]
- 8. Cook PJ, Lip GYH: Infectious agents and atherosclerotic vascular disease. Q J Med 1996; 89: 727–735 [DOI] [PubMed] [Google Scholar]
- 9. Libby P, Egan D, Skarlatos S: Roles of infectious agents in atherosclerosis and restenosis. Circulation 1997; 96: 4095–4103 [DOI] [PubMed] [Google Scholar]
- 10. Nicholson AC, Hajjar DP: Herpesviruses in atherosclerosis and thrombosis, Etiologic agents or ubiquitious bystandards? Arterioscler Tromb Vasc Biol 1998; 18: 339–348 [DOI] [PubMed] [Google Scholar]
- 11. CASS Principal Investigators and Associates : Coronary artery surgery study (CASS): A randomized trial of coronary artery bypass surgery. Circulation 1983; 68: 939–950 [DOI] [PubMed] [Google Scholar]
- 12. Principal Investigators of CASS and Associates : National Heart, Lung, and Blood Institute Coronary Artery Study 1. Circulation 1981; 63 (suppl 1): I‐41‐20 [Google Scholar]
- 13. Araki A, Sako Y: Determination of free and total homocysteine in human plasma by high performance liquid chromatography with fluorescence detection. J Chromatogr 1987; 422: 43–52 [DOI] [PubMed] [Google Scholar]
- 14. Gurfinkel E, Bozovich G, Daroca A, Beck E, Mautner B, for the ROXIS Study Group : Randomised trial of roxithromycine in non‐Q wave coronary syndromes: ROXIS pilot study. Lancet 1997; 350: 404–407 [DOI] [PubMed] [Google Scholar]
- 15. Puurunen M, Manttari M, Manninen V, Tenkanen L, Alfthan G, Ehnholm C, Vaarala O, Aho K, Paslosuo T: Antibodies against oxidized low density lipoprotein predicting myocardial infarction. Arch Intern Med 1994; 154: 2605–2609 [PubMed] [Google Scholar]
- 16. Blank M, Cohen J, Toder V, Shoenfeld Y: Induction of anti‐phospholipid syndrome in naive mice with lupus monoclonal and human polyclonal anti‐cardiolipin antibodies. Proc Natl Acad Sci USA 1991; 88: 3069–3073 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Vaarala O, Manttari M, Manninen V, Tenkanen L, Puurunen M, Aho K, Palosuo T: Anti‐cardiolipin antibodies and risk of myocardial infarction in a prospective cohort of middle‐aged men. Circulation 1995; 91: 23–27 [DOI] [PubMed] [Google Scholar]
- 18. McNeil HP, Simpson RJ, Chesterman CN, Krilis SA: Antiphospholipid antibodies are directed against a complex antigen that includes a lipid binding inhibitor of coagulation: b̃2GPI (apolipoprotein H). Proc Natl Acad Sci USA 1990; 87: 4120–4124 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. George J, Afek A, Gilburd B, Levy Y, Blank M, Aron‐Maor A, Shaish A, Levkovitz H, Goldberg I, Kopolovic J, Harats D, Shoenfeld Y: Induction of early atherosclerosis in LDL receptor deficient mice by immunization with beta 2 glycoproein I. Circulation (in press) [DOI] [PubMed]
- 20. Lauerta P, Azen SP, LaBree L: Use of neural networks in predicting the risk of coronary artery disease. Comput Biomed Res 1995; 28: 38–52 [DOI] [PubMed] [Google Scholar]